Allogene (ALLO) Q1 2026 Earnings Transcript
Source: Motley Fool
2026-05-13 18:38:14 ET
Image source: The Motley Fool.
Wednesday, May 13, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Allogene Therapeutics Inc.
NASDAQ: ALLO
ALLO Trading
-4.74% G/L:
$1.9147 Last:
4,997,817 Volume:
$1.97 Open:
ALLO Latest News
May 26, 2026 08:30:00 am
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
May 13, 2026 04:02:00 pm
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
$391,030,451
154,982,897
0.82%
58
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
